NOVO NORDISK A/SNOVO NORDISK A/SNOVO NORDISK A/S

NOVO NORDISK A/S

No trades
See on Supercharts

Key facts today

Novo Nordisk's obesity medication Wegovy has been added to the eligibility guidelines by NICE for patients with weight-related conditions, aligning it with the recently approved Mounjaro by Eli Lilly.
Analyze the impactAnalyze the impact
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪7.35 T‬MXN
60.90MXN
‪206.24 B‬MXN
‪572.40 B‬MXN
‪3.34 B‬
Beta (1Y)
1.03

About NOVO NORDISK B A/S


CEO
Lars Fruergaard Jørgensen
Headquarters
Bagsværd
Founded
1931
FIGI
BBG007QV72Q7
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
N
XS282046075
NOVO NO.F.NL 24/34 MTN
Yield to maturity
3.12%
Maturity date
May 21, 2034
N
XS282045567
NOVO NO.F.NL 24/31 MTN
Yield to maturity
2.84%
Maturity date
Jan 21, 2031
XS244124704
NOVO NO.F.NL 22/30MTN
Yield to maturity
2.81%
Maturity date
Mar 31, 2030
N
XS282045460
NOVO NO.F.NL 24/29 MTN
Yield to maturity
2.71%
Maturity date
Jan 21, 2029
XS234803042
NOVO NO.F.NL 21/28
Yield to maturity
2.69%
Maturity date
Jun 4, 2028
N
XS282044994
NOVO NO.F.NL 24/26 MTN
Yield to maturity
2.65%
Maturity date
May 21, 2026
XS244124453
NOVO NO.F.NL 22/25 MTN
Yield to maturity
2.62%
Maturity date
Mar 31, 2025
XS244933017
NOVO NO.F.NL 22/27MTN
Yield to maturity
2.43%
Maturity date
Sep 30, 2027

Explore more bonds